Literature DB >> 1602480

Refined crystal structure of a recombinant immunoglobulin domain and a complementarity-determining region 1-grafted mutant.

B Steipe1, A Plückthun, R Huber.   

Abstract

We report the solution of the crystal structure of a mutant of the immunoglobulin VL domain of the antibody McPC603, in which the complementarity-determining region 1 segment is replaced with that of a different antibody. The wild-type and mutant crystal structures have been refined to a crystallographic R-factor of 14.9% at a nominal resolution of 1.97 A. A detailed description of the structures is given. Crystal packing results in a dimeric association of domains, in a fashion closely resembling that of an Fv fragment. The comparison of this VL domain with the same domain in the Fab fragment of McPC603 shows that the structure of an immunoglobulin VL domain is largely independent of its mode of association, even in places where the inter-subunit contacts are not conserved between VL and VH. In all three complementarity-determining regions we observe conformations that would not have been predicted by the canonical structure hypothesis. Significant differences between the VL domain dimer and the Fab fragment in the third complementarity-determining region show that knowledge of the structure of the dimerization partner and its exact mode of association may be needed to predict the precise conformation of antigen-binding loops.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1602480     DOI: 10.1016/0022-2836(92)90398-4

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

1.  Direct evidence by H/D exchange and ESI-MS for transient unproductive domain interaction in the refolding of an antibody scFv fragment.

Authors:  M Jäger; A Plückthun
Journal:  Protein Sci       Date:  2000-03       Impact factor: 6.725

2.  Change in dimerization mode by removal of a single unsatisfied polar residue located at the interface.

Authors:  P R Pokkuluri; X Cai; G Johnson; F J Stevens; M Schiffer
Journal:  Protein Sci       Date:  2000-09       Impact factor: 6.725

3.  Rapid purification and crystal structure analysis of a small protein carrying two terminal affinity tags.

Authors:  Uwe Mueller; Konrad Büssow; Anne Diehl; Franz J Bartl; Frank H Niesen; Lajos Nyarsik; Udo Heinemann
Journal:  J Struct Funct Genomics       Date:  2003

4.  Increasing protein stability by polar surface residues: domain-wide consequences of interactions within a loop.

Authors:  P R Pokkuluri; R Raffen; L Dieckman; C Boogaard; F J Stevens; M Schiffer
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

5.  Beta-turn propensities as paradigms for the analysis of structural motifs to engineer protein stability.

Authors:  E C Ohage; W Graml; M M Walter; S Steinbacher; B Steipe
Journal:  Protein Sci       Date:  1997-01       Impact factor: 6.725

Review 6.  Antibody-combining sites. Extending the natural limits.

Authors:  D M Webster; J Pedersen; D Staunton; A Jones; A R Rees
Journal:  Appl Biochem Biotechnol       Date:  1994 May-Jun       Impact factor: 2.926

7.  Defining the complementarities between antibodies and haptens to refine our understanding and aid the prediction of a successful binding interaction.

Authors:  Mohammed M Al Qaraghuli; Soumya Palliyil; Gillian Broadbent; David C Cullen; Keith A Charlton; Andrew J Porter
Journal:  BMC Biotechnol       Date:  2015-10-24       Impact factor: 2.563

8.  Factors contributing to decreased protein stability when aspartic acid residues are in beta-sheet regions.

Authors:  P R Pokkuluri; M Gu; X Cai; R Raffen; F J Stevens; M Schiffer
Journal:  Protein Sci       Date:  2002-07       Impact factor: 6.725

9.  Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein.

Authors:  Constanze Breithaupt; Anna Schubart; Hilke Zander; Arne Skerra; Robert Huber; Christopher Linington; Uwe Jacob
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-21       Impact factor: 11.205

10.  The structural repertoire of the human V kappa domain.

Authors:  I M Tomlinson; J P Cox; E Gherardi; A M Lesk; C Chothia
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.